Glucocorticoid Effects on Immune Responses

NeuroImmune Biology

Volumn 7, Issue C, 2007, Pages 147-167

  Guyre, Paul M ^a   Yeager, Mark P ^a   Munck, Allan ^a  

^a DARTMOUTH MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 70349654488     PISSN: 15677443     EISSN: None     Source Type: Book Series    
DOI: 10.1016/S1567-7443(07)00208-6     Document Type: Review

References (165)

1. Hench P.S., Kendall E.C., Slocumb C.H., and Polley H.F. The effect of a hormone of the adrenal cortex (17-hydroxy-11-dehydrocorticosterone: compound E) and of pituitary adrenocorticotropic hormone on rheumatoid arthritis. Mayo Clin Proc 24 (1949) 181-197
2. Tausk M. Hat die Nebenniere tatsächlich eine Verteidigungsfunktion?. Das Hormon (Organon, Holland) 3 (1951) 1-24
3. Munck A., Guyre P.M., and Holbrook N.J. Physiological functions of glucocorticoids in stress and their relation to pharmacological actions. Endocr Rev 5 (1984) 25-44
4. Sapolsky R.M., Romero L.M., and Munck A. How do glucocorticoids influence stress-responses? Integrating permissive, suppressive, stimulatory, and preparative actions. Endocr Rev 21 (2000) 55-89
5. Besedovsky H., and Sorkin E. Network of immune-neuroendocrine interactions. Clin Exp Immunol 27 (1977) 1-12
6. Munck A., and Náray-Fejes-Tóth A. The ups and downs of glucocorticoid physiology. Permissive and suppressive effects revisited. Mol Cell Endocrinol 90 (1992) C1-C4
7. Munck A., and Náray-Fejes-Tóth A. Glucocorticoids and stress: permissive and suppressive actions. Ann N Y Acad Sci 746 (1994) 115-130
8. Charmandari E., Tsigos C., and Chrousos G. Endocrinology of the stress response. Annu Rev Physiol 67 (2005) 259-284
9. Franchimont D. Overview of the actions of glucocorticoids on the immune response: a good model to characterize new pathways of immunosuppression for new treatment strategies. Ann N Y Acad Sci 1024 (2004) 124-137
10. Herold M.J., McPherson K.G., and Reichardt H.M. Glucocorticoids in T cell apoptosis and function. Cell Mol Life Sci 63 (2006) 60-72
11. Sorrells S.F., and Sapolsky R.M. An inflammatory review of glucocorticoid actions in the CNS. Brain Behav Immun 21 (2007) 259-272
12. Yeager M.P., Guyre P.M., and Munck A.U. Glucocorticoid regulation of the inflammatory response to injury. Acta Anaesthesiol Scand 48 (2004) 799-813
13. Wiegers G.J., and Reul J.M.H.M. Induction of cytokine receptors by glucocorticoids: functional and pathological significance. Trends Pharmacol Sci 19 (1998) 317-321
14. Wang J., Zhu Z., Nolfo R., and Elias J.A. Dexamethasone regulation of lung epithelial cell and fibroblast interleukin-11 production. Am J Physiol 276 (1999) L175-L185
15. Yoshikawa H., Nakajima Y., and Tasaka K. Glucocorticoid suppresses autocrine survival of mast cells by inhibiting IL-4 production and ICAM-1 expression. J Immunol 162 (1999) 6162-6170
16. Sapolsky R.M. Glucocorticoids and hippocampal atrophy in neuropsychiatric disorders. Arch Gen Psychiatry 57 (2000) 925-935
17. Nissen R.M., and Yamamoto K.R. The glucocorticoid receptor inhibits NFkB by interfering with serine-2 phosphorylation of the RNA polymerase II carboxy-terminal domain. Genes Dev 14 (2000) 2314-2329
18. Smith P.J., Cousins D.J., Jee Y.K., Staynov D.Z., Lee T.H., and Lavender P. Suppression of granulocyte-macrophage colony-stimulating factor expression by glucocorticoids involves inhibition of enhancer function by the glucocorticoid receptor binding to composite NF-AT/activator protein-1 elements. J Immunol 167 (2001) 2502-2510
19. Ammit A.J., Lazaar A.L., Irani C., et al. Tumor necrosis factor-α-induced secretion of RANTES and interleukin-6 from human airway smooth muscle cells: modulation by glucocorticoids and β-agonists. Am J Respir Cell Mol Biol 26 (2002) 465-474
20. Pitzalis C., Pipitone N., and Perretti M. Regulation of leukocyte-endothelial interactions by glucocorticoids. Ann N Y Acad Sci 966 (2002) 108-118
21. Umland S.P., Schleimer R.P., and Johnston S.L. Review of the molecular and cellular mechanisms of action of glucocorticoids for use in asthma. Pulm Pharmacol Ther 15 (2002) 35-50
22. Da Silva C.A., Kassel O., Mathieu E., Massard G., Gasser B., and Frossard N. Inhibition by glucocorticoids of the interleukin-1β-enhanced expression of the mast cell growth factor SCF. Br J Pharmacol 135 (2002) 1634-1640
23. Almawi W.Y., and Melemedjian O.K. Molecular mechanisms of glucocorticoid antiproliferative effects: antagonism of transcription factor activity by glucocorticoid receptor. J Leukoc Biol 71 (2002) 9-15
24. Eberhardt W., Schulze M., Engels C., Klasmeier E., and Pfeilschifter J. Glucocorticoid-mediated suppression of cytokine-induced matrix metalloproteinase-9 expression in rat mesangial cells: involvement of nuclear factor-κB and Ets transcription factors. Mol Endocrinol 16 (2002) 1752-1766
25. Petrovsky N., and Harrison L.C. The chronobiology of human cytokine production. Int Rev Immunol 16 (1998) 635-649
26. Hrushesky W.J., Langevin T., Kim Y.J., and Wood P.A. Circadian dynamics of tumor necrosis factor alpha (cachectin) lethality. J Exp Med 180 (1994) 1059-1065
27. Barber A.E., Coyle S.M., Fischer E., et al. Influence of hypercortisolemia on soluble tumor necrosis factor receptor II and interleukin-1 receptor antagonist responses to endotoxin in human beings. Surgery 118 (1995) 406-410 discussion 410-1
28. Barber A.E., Coyle S.M., Marano M.A., et al. Glucocorticoid therapy alters hormonal and cytokine responses to endotoxin in man. J Immunol 150 (1993) 1999-2006
29. Caulfield J., Fernandez M., Snetkov V., Lee T., and Hawrylowicz C. CXCR4 expression on monocytes is up-regulated by dexamethasone and is modulated by autologous CD3+ T cells. Immunology 105 (2002) 155-162
30. Franchimont D., Galon J., Vacchio M.S., et al. Positive effects of glucocorticoids on T cell function by up-regulation of IL-7 receptor α. J Immunol 168 (2002) 2212-2218
31. Hawrylowicz C.M., Guida L., and Paleolog E. Dexamethasone up-regulates granulocyte-macrophage colony-stimulating factor receptor expression on human monocytes. Immunology 83 (1994) 274-280
32. Baker J.B., Barsh G.S., Carney D.H., and Cunningham D.D. Dexamethasone modulates binding and action of epidermal growth factor in serum-free culture. Proc Natl Acad Sci USA 75 (1978) 1882-1886
33. Arzt E., Kovalovsky D., Igaz L.M., et al. Functional cross-talk among cytokines, T-cell receptor, and glucocorticoid receptor transcriptional activity and action. Ann N Y Acad Sci 917 (2000) 672-677
34. Biola A., Lefebvre P., Perrin-Wolff M., Sturm M., Bertoglio J., and Pallardy M. Interleukin-2 inhibits glucocorticoid receptor transcriptional activity through a mechanism involving STAT5 (signal transducer and activator of transcription 5) but not AP-1. Mol Endocrinol 15 (2001) 1062-1076
35. Heiniger C.D., Rochat M.K., Frey F.J., and Frey B.M. TNF-α enhances intracellular glucocorticoid availability. FEBS Lett 507 (2001) 351-356
36. Chapman K.E., Coutinho A., Gray M., Gilmour J.S., Savill J.S., and Seckl J.R. Local amplification of glucocorticoids by 11beta-hydroxysteroid dehydrogenase type 1 and its role in the inflammatory response. Ann N Y Acad Sci 1088 (2006) 265-273
37. Chapman K.E., Gilmour J.S., Coutinho A.E., Savill J.S., and Seckl J.R. 11Beta-hydroxysteroid dehydrogenase type 1 - a role in inflammation?. Mol Cell Endocrinol 248 (2006) 3-8
38. Calandra T., Bernhagen J., Metz C.N., et al. MIF as a glucocorticoid-induced modulator of cytokine production. Nature 377 (1995) 68-71
39. Lolis E. Glucocorticoid counter regulation: macrophage migration inhibitory factor as a target for drug discovery. Curr Opin Pharmacol 1 (2001) 662-668
40. Flaster H., Bernhagen J., Calandra T., and Bucala R. The macrophage migration inhibitory factor-glucocorticoid dyad: regulation of inflammation and immunity. Mol Endocrinol 21 (2007) 1267-1280
41. Morand E.F., Leech M., and Bernhagen J. MIF: a new cytokine link between rheumatoid arthritis and atherosclerosis. Nat Rev Drug Discov 5 (2006) 399-410
42. Kudrin A., Scott M., Martin S., et al. Human macrophage migration inhibitory factor: a proven immunomodulatory cytokine?. J Biol Chem 281 (2006) 29641-29651
43. Aeberli D., Leech M., and Morand E.F. Macrophage migration inhibitory factor and glucocorticoid sensitivity. Rheumatology (Oxford) 45 (2006) 937-943
44. Aeberli D., Yang Y., Mansell A., Santos L., Leech M., and Morand E.F. Endogenous macrophage migration inhibitory factor modulates glucocorticoid sensitivity in macrophages via effects on MAP kinase phosphatase-1 and p38 MAP kinase. FEBS Lett 580 (2006) 974-981
45. Bornstein S.R., Ziegler C.G., Krug A.W., et al. The role of Toll-like receptors in the immune-adrenal crosstalk. Ann N Y Acad Sci 1088 (2006) 307-318
46. Zhao Q., Wang X., Nelin L.D., et al. MAP kinase phosphatase 1 controls innate immune responses and suppresses endotoxic shock. J Exp Med 203 (2006) 131-140
47. Baumann H., and Gauldie J. The acute phase response. Immunol Today 15 (1994) 74-80
48. Thorn C.F., and Whitehead A.S. Differential glucocorticoid enhancement of the cytokine-driven transcriptional activation of the human acute phase serum amyloid A genes, SAA1 and SAA2. J Immunol 169 (2002) 399-406
49. Fischer C.P., Bode B.P., Takahashi K., Tanabe K.K., and Souba W.W. Glucocorticoid-dependent induction of interleukin-6 receptor expression in human hepatocytes facilitates interleukin-6 stimulation of amino acid transport. Ann Surg 223 (1996) 610-618 discussion 618-19
50. Medzhitov R., and Janeway Jr. C.A. Decoding the patterns of self and nonself by the innate immune system. Science 296 (2002) 298-300
51. Janeway Jr. C.A., and Medzhitov R. Innate immune recognition. Annu Rev Immunol 20 (2002) 197-216
52. Zacharowski K., Zacharowski P.A., Koch A., et al. Toll-like receptor 4 plays a crucial role in the immune-adrenal response to systemic inflammatory response syndrome. Proc Natl Acad Sci USA 103 (2006) 6392-6397
53. Ogawa S., Lozach J., Benner C., et al. Molecular determinants of crosstalk between nuclear receptors and Toll-like receptors. Cell 122 (2005) 707-721
54. Kapcala L.P., Chautard T., and Eskay R.L. The protective role of the hypothalamic-pituitary-adrenal axis against lethality produced by immune, infectious, and inflammatory stress. Ann N Y Acad Sci 771 (1995) 419-437
55. Reichardt H.M., Umland T., Bauer A., Kretz O., and Schutz G. Mice with an increased glucocorticoid receptor gene dosage show enhanced resistance to stress and endotoxic shock. Mol Cell Biol 20 (2000) 9009-9017
56. Bhattacharyya S., Brown D.E., Brewer J.A., Vogt S.K., and Muglia L.J. Macrophage glucocorticoid receptors regulate Toll-like receptor-4-mediated inflammatory responses by selective inhibition of p38 MAP kinase. Blood 109 (2007) 4313-4319
57. Marchant A., Bruyns C., Vandenabeele P., et al. Interleukin-10 controls interferon-γ and tumor necrosis factor production during experimental endotoxemia. Eur J Immunol 24 (1994) 1167-1171
58. Gerard C., Bruyns C., Marchant A., et al. Interleukin 10 reduces the release of tumor necrosis factor and prevents lethality in experimental endotoxemia. J Exp Med 177 (1993) 547-550
59. Howard M., Muchamuel T., Andrade S., and Menon S. Interleukin 10 protects mice from lethal endotoxemia. J Exp Med 177 (1993) 1205-1208
60. Standiford T.J., Strieter R.M., Lukacs N.W., and Kunkel S.L. Neutralization of IL-10 increases lethality in endotoxemia. Cooperative effects of macrophage inflammatory protein-2 and tumor necrosis factor. J Immunol 155 (1995) 2222-2229
61. Mozo L., Suarez A., and Gutierrez C. Glucocorticoids up-regulate constitutive interleukin-10 production by human monocytes. Clin Exp Allergy 34 (2004) 406-412
62. Fillinger M.P., Rassias A.J., Guyre P.M., et al. Glucocorticoid effects on the inflammatory and clinical responses to cardiac surgery. J Cardiothorac Vasc Anesth 16 (2002) 163-169
63. van der Poll T., Barber A.E., Coyle S.M., and Lowry S.F. Hypercortisolemia increases plasma interleukin-10 concentrations during human endotoxemia - a clinical research center study. J Clin Endocrinol Metab 81 (1996) 3604-3606
64. Fearon D.T., and Locksley R.M. The instructive role of innate immunity in the acquired immune response. Science 272 (1996) 50-53
65. Braun-Fahrlander C., Riedler J., Herz U., et al. Environmental exposure to endotoxin and its relation to asthma in school-age children. N Engl J Med 347 (2002) 869-877
66. Shanks N., Windle R.J., Perks P.A., et al. Early-life exposure to endotoxin alters hypothalamic-pituitary-adrenal function and predisposition to inflammation. Proc Natl Acad Sci USA 97 (2000) 5645-5650
67. Nau G.J., Richmond J.F., Schlesinger A., Jennings E.G., Lander E.S., and Young R.A. Human macrophage activation programs induced by bacterial pathogens. Proc Natl Acad Sci USA 99 (2002) 1503-1508
68. Galon J., Franchimont D., Hiroi N., et al. Gene profiling reveals unknown enhancing and suppressive actions of glucocorticoids on immune cells. FASEB J 16 (2002) 61-71
69. Donn R., Berry A., Stevens A., et al. Use of gene expression profiling to identify a novel glucocorticoid sensitivity determining gene, BMPRII. FASEB J 21 (2007) 402-414
70. Franchimont D., Martens H., Hagelstein M.-T., et al. Tumor necrosis factor α decreases, and interleukin-10 increases, the sensitivity of human monocytes to dexamethasone: potential regulation of the glucocorticoid receptor. J Clin Endocrinol Metab 84 (1999) 2834-2839
71. Schmidt M., Pauels H.-G., Lügering N., Lügering A., Domschke W., and Kucharzik T. Glucocorticoids induce apoptosis in human monocytes: potential role of IL-1β. J Immunol 163 (1999) 3484-3490
72. Snyder D.S., and Unanue E.R. Corticosteroids inhibit murine macrophage Ia expression and interleukin 1 production. J Immunol 129 (1982) 1803-1805
73. Gerrard T.L., Cupps T.R., Jurgensen C.H., and Fauci A.S. Hydrocortisone-mediated inhibition of monocyte antigen presentation: dissociation of inhibitory effect and expression of DR antigens. Cell Immunol 85 (1984) 330-339
74. Girndt M., Sester U., Kaul H., Hunger F., and Kohler H. Glucocorticoids inhibit activation-dependent expression of costimulatory molecule B7-1 in human monocytes. Transplantation 66 (1998) 370-375
75. Tuckermann J.P., Kleiman A., Moriggl R., et al. Macrophages and neutrophils are the targets for immune suppression by glucocorticoids in contact allergy. J Clin Invest 117 (2007) 1381-1390
76. Lutz M., and Schuler G. Immature, semi-mature and fully mature dendritic cells: which signals induce tolerance or immunity?. Trends Immunol 23 (2002) 445
77. van den Heuvel M.M., van Beek N.M., Broug-Holub E., et al. Glucocorticoids modulate the development of dendritic cells from blood precursors. Clin Exp Immunol 115 (1999) 577-583
78. Vanderheyde N., Verhasselt V., Goldman M., and Willems F. Inhibition of human dendritic cell functions by methylprednisolone. Transplantation 67 (1999) 1342-1347
79. Piemonti L., Monti P., Allavena P., et al. Glucocorticoids affect human dendritic cell differentiation and maturation. J Immunol 162 (1999) 6473-6481
80. Woltman A.M., de Fijter J.W., Kamerling S.W., Paul L.C., Daha M.R., and van Kooten C. The effect of calcineurin inhibitors and corticosteroids on the differentiation of human dendritic cells. Eur J Immunol 30 (2000) 1807-1812
81. Woltman A.M., Massacrier C., de Fijter J.W., Caux C., and van Kooten C. Corticosteroids prevent generation of CD34+-derived dermal dendritic cells but do not inhibit Langerhans cell development. J Immunol 168 (2002) 6181-6288
82. de Jong E.C., Vieira P.L., Kalinski P., and Kapsenberg M.L. Corticosteroids inhibit the production of inflammatory mediators in immature monocyte-derived DC and induce the development of tolerogenic DC3. J Leukoc Biol 66 (1999) 201-204
83. Rea D., van Kooten C., van Meijgaarden K.E., Ottenhoff T.H., Melief C.J., and Offringa R. Glucocorticoids transform CD40-triggering of dendritic cells into an alternative activation pathway resulting in antigen-presenting cells that secrete IL-10. Blood 95 (2000) 3162-3167
84. Wiley R.E., Cwiartka M., Alvarez D., et al. Transient corticosteroid treatment permanently amplifies the Th2 response in a murine model of asthma. J Immunol 172 (2004) 4995-5005
85. Cohen N., Mouly E., Hamdi H., et al. GILZ expression in human dendritic cells redirects their maturation and prevents antigen-specific T lymphocyte response. Blood 107 (2006) 2037-2044
86. Berrebi D., Bruscoli S., Cohen N., et al. Synthesis of glucocorticoid-induced leucine zipper (GILZ) by macrophages: an anti-inflammatory and immunosuppressive mechanism shared by glucocorticoids and IL-10. Blood 101 (2003) 729-738
87. Hamdi H., Godot V., Maillot M.C., et al. Induction of antigen-specific regulatory T lymphocytes by human dendritic cells expressing the glucocorticoid-induced leucine zipper. Blood 110 (2007) 211-219
88. Eddleston J., Herschbach J., Wagelie-Steffen A.L., Christiansen S.C., and Zuraw B.L. The anti-inflammatory effect of glucocorticoids is mediated by glucocorticoid-induced leucine zipper in epithelial cells. J Allergy Clin Immunol 119 (2007) 115-122
89. Nocentini G., and Riccardi C. GITR, a multifaceted regulator of immunity belonging to the tumor necrosis factor receptor superfamily. Eur J Immunol 35 (2005) 1016-1022
90. Shevach E.M., and Stephens G.L. The GITR-GITRL interaction: co-stimulation or contrasuppression of regulatory activity?. Nat Rev Immunol 6 (2006) 613-618
91. Grohmann U., Volpi C., Fallarino F., et al. Reverse signaling through GITR ligand enables dexamethasone to activate IDO in allergy. Nat Med 13 (2007) 579-586
92. Billingham R.E., Krohn P.L., and Medawar P.B. Effect of cortisone on survival of skin homografts in rabbits. Br Med J 1 (1951) 1157-1163
93. Ashwell J.D., Lu F.W., and Vacchio M.S. Glucocorticoids in T cell development and function. Annu Rev Immunol 18 (2000) 309-345
94. Wiegers G.J., Knoflach M., Bock G., et al. CD4(+)CD8(+)TCR(low) thymocytes express low levels of glucocorticoid receptors while being sensitive to glucocorticoid-induced apoptosis. Eur J Immunol 31 (2001) 2293-2301
95. Pazirandeh A., Xue Y., Prestegaard T., Jondal M., and Okret S. Effects of altered glucocorticoid sensitivity in the T cell lineage on thymocyte and T cell homeostasis. FASEB J 16 (2002) 727-729
96. Winoto A., and Littman D.R. Nuclear hormone receptors in T lymphocytes. Cell 109 Suppl (2002) S57-S66
97. Zacharchuk C.M., Mercep M., Chakraborti P.K., Simons Jr. S.S., and Ashwell J.D. Programmed T lymphocyte death. Cell activation- and steroid-induced pathways are mutually antagonistic. J Immunol 145 (1990) 4037-4045
98. Erlacher M., Knoflach M., Stec I.E., Bock G., Wick G., and Wiegers G.J. TCR signaling inhibits glucocorticoid-induced apoptosis in murine thymocytes depending on the stage of development. Eur J Immunol 35 (2005) 3287-3296
99. Van Laethem F., Baus E., Smyth L.A., et al. Glucocorticoids attenuate T cell receptor signaling. J Exp Med 193 (2001) 803-814
100. Mittelstadt P.R., and Ashwell J.D. Inhibition of AP-1 by the glucocorticoid-inducible protein GILZ. J Biol Chem 276 (2001) 29603-29610
101. Purton J.F., Boyd R.L., Cole T.J., and Godfrey D.I. Intrathymic T cell development and selection proceeds normally in the absence of glucocorticoid receptor signaling. Immunity 13 (2000) 179-186
102. Ramírez F., Fowell D.J., Puclavec M., Simmonds S., and Mason D. Glucocorticoids promote a Th2 cytokine response by CD4+ T cells in vitro. J Immunol 156 (1996) 2406-2412
103. Shevach E.M. CD4+ CD25+ suppressor T cells: more questions than answers. Nat Rev Immunol 2 (2002) 389-400
104. McGuirk P., and Mills K. Pathogen-specific regulatory T cells provoke a shift in the Th1/Th2 paradigm in immunity to infectious diseases. Trends Immunol 23 (2002) 450
105. Zelenika D., Adams E., Humm S., et al. Regulatory T cells overexpress a subset of Th2 gene transcripts. J Immunol 168 (2002) 1069-1079
106. Barrat F.J., Cua D.J., Boonstra A., et al. In vitro generation of interleukin 10-producing regulatory CD4(+) T cells is induced by immunosuppressive drugs and inhibited by T helper type 1 (Th1)- and Th2-inducing cytokines. J Exp Med 195 (2002) 603-616
107. Chen X., Murakami T., Oppenheim J.J., and Howard O.M. Differential response of murine CD4+CD25+ and CD4+CD25- T cells to dexamethasone-induced cell death. Eur J Immunol 34 (2004) 859-869
108. Agarwal S.K., and Marshall Jr. G.D. Dexamethasone promotes type 2 cytokine production primarily through inhibition of type 1 cytokines. J Interferon Cytokine Res 21 (2001) 147-155
109. Morand E.F. Effects of glucocorticoids on inflammation and arthritis. Curr Opin Rheumatol 19 (2007) 302-307
110. Webster J.I., Tonelli L., and Sternberg E.M. Neuroendocrine regulation of immunity. Annu Rev Immunol 20 (2002) 125-163
111. Tabardel Y., Duchateau J., Schmartz D., et al. Corticosteroids increase blood interleukin-10 levels during cardiopulmonary bypass in men. Surgery 119 (1996) 76-80
112. Tassani P., Richter J.A., Barankay A., et al. Does high-dose methylprednisolone in aprotinin-treated patients attenuate the systemic inflammatory response during coronary artery bypass grafting procedures?. J Cardiothorac Vasc Anesth 13 (1999) 165-172
113. Dandona P., Aljada A., Garg R., and Mohanty P. Increase in plasma interleukin-10 following hydrocortisone injection. J Clin Endocrinol Metab 84 (1999) 1141-1144
114. Lim H.Y., Muller N., Herold M.J., van den Brandt J., and Reichardt H.M. Glucocorticoids exert opposing effects on macrophage function dependent on their concentration. Immunology 122 (2007) 47-53
115. Zhang T.Y., and Daynes R.A. Glucocorticoid conditioning of myeloid progenitors enhances TLR4 signaling via negative regulation of the phosphatidylinositol 3-kinase-Akt pathway. J Immunol 178 (2007) 2517-2526
116. Pajkrt D., Camoglio L., Tiel-van Buul M.C., et al. Attenuation of proinflammatory response by recombinant human IL-10 in human endotoxemia: effect of timing of recombinant human IL-10 administration. J Immunol 158 (1997) 3971-3977
117. Lauw F.N., Pajkrt D., Hack C.E., Kurimoto M., van Deventer S.J., and van der Poll T. Proinflammatory effects of IL-10 during human endotoxemia. J Immunol 165 (2000) 2783-2789
118. de Kruif M.D., Lemaire L.C., Giebelen I.A., et al. Prednisolone dose-dependently influences inflammation and coagulation during human endotoxemia. J Immunol 178 (2007) 1845-1851
119. Cox G. Glucocorticoid treatment inhibits apoptosis in human neutrophils. Separation of survival and activation outcomes. J Immunol 154 (1995) 4719-4725
120. Meagher L.C., Cousin J.M., Seckl J.R., and Haslett C. Opposing effects of glucocorticoids on the rate of apoptosis in neutrophilic and eosinophilic granulocytes. J Immunol 156 (1996) 4422-4428
121. Ertel W., Keel M., Infanger M., Ungethum U., Steckholzer U., and Trentz O. Circulating mediators in serum of injured patients with septic complications inhibit neutrophil apoptosis through up-regulation of protein-tyrosine phosphorylation. J Trauma 44 (1998) 767-775 discussion 775-6
122. Ogura H., Tanaka H., Koh T., et al. Priming, second-hit priming, and apoptosis in leukocytes from trauma patients. J Trauma 46 (1999) 774-781 discussion 781-3
123. Murphy T.J., Paterson H.M., Kriynovich S., et al. Linking the "two-hit" response following injury to enhanced TLR4 reactivity. J Leukoc Biol 77 (2005) 16-23
124. Heasman S.J., Giles K.M., Ward C., Rossi A.G., Haslett C., and Dransfield I. Glucocorticoid-mediated regulation of granulocyte apoptosis and macrophage phagocytosis of apoptotic cells: implications for the resolution of inflammation. J Endocrinol 178 (2003) 29-36
125. McWilliam A.S., Tree P., and Gordon S. Interleukin 4 regulates induction of sialoadhesin, the macrophage sialic acid-specific receptor. Proc Natl Acad Sci USA 89 (1992) 10522-10526
126. Martinez F.O., Gordon S., Locati M., and Mantovani A. Transcriptional profiling of the human monocyte-to-macrophage differentiation and polarization: new molecules and patterns of gene expression. J Immunol 177 (2006) 7303-7311
127. Goerdt S., and Orfanos C.E. Other functions, other genes: alternative activation of antigen-presenting cells. Immunity 10 (1999) 137-142
128. Schebesch C., Kodelja V., Muller C., et al. Alternatively activated macrophages actively inhibit proliferation of peripheral blood lymphocytes and CD4+ T cells in vitro. Immunology 92 (1997) 478-486
129. Gratchev A., Guillot P., Hakiy N., et al. Alternatively activated macrophages differentially express fibronectin and its splice variants and the extracellular matrix protein betaIG-H3. Scand J Immunol 53 (2001) 386-392
130. Rhen T., and Cidlowski J.A. Antiinflammatory action of glucocorticoids - new mechanisms for old drugs. N Engl J Med 353 (2005) 1711-1723
131. Eggert M., Schulz M., and Neeck G. Molecular mechanisms of glucocorticoid action in rheumatic autoimmune diseases. J Steroid Biochem Mol Biol 77 (2001) 185-191
132. Liberman A.C., Druker J., Perone M.J., and Arzt E. Glucocorticoids in the regulation of transcription factors that control cytokine synthesis. Cytokine Growth Factor Rev 18 (2007) 45-56
133. Wehling H. Specific, nongenomic actions of steroid hormones. Annu Rev Physiol 59 (1997) 365-393
134. Hafezi-Moghadam A., Simoncini T., Yang E., et al. Acute cardiovascular protective effects of corticosteroids are mediated by non-transcriptional activation of endothelial nitric oxide synthase. Nat Med 8 (2002) 473-479
135. Watson C.S., and Gametchu B. Membrane estrogen and glucocorticoid receptors - implications for hormonal control of immune function and autoimmunity. Int Immunopharmacol 1 (2001) 1049-1063
136. Buttgereit F., and Scheffold A. Rapid glucocorticoid effects on immune cells. Steroids 67 (2002) 529-534
137. DeRijk R., and de Kloet E.R. Corticosteroid receptor genetic polymorphisms and stress responsivity. Endocrine 28 (2005) 263-270
138. Kozaci D.L., Chernajovsky Y., and Chikanza I.C. The differential expression of corticosteroid receptor isoforms in corticosteroid-resistant and -sensitive patients with rheumatoid arthritis. Rheumatology (Oxford) 46 (2007) 579-585
139. Goleva E., Li L.B., Eves P.T., Strand M.J., Martin R.J., and Leung D.Y. Increased glucocorticoid receptor beta alters steroid response in glucocorticoid-insensitive asthma. Am J Respir Crit Care Med 173 (2006) 607-616
140. Yudt M.R., and Cidlowski J.A. The glucocorticoid receptor: coding a diversity of proteins and responses through a single gene. Mol Endocrinol 16 (2002) 1719-1726
141. Li L.B., Leung D.Y., Hall C.F., and Goleva E. Divergent expression and function of glucocorticoid receptor beta in human monocytes and T cells. J Leukoc Biol 79 (2006) 818-827
142. Strickland I., Kisich K., Hauk P.J., et al. High constitutive glucocorticoid receptor β in human neutrophils enables them to reduce their spontaneous rate of cell death in response to corticosteroids. J Exp Med 193 (2001) 585-594
143. Funder J.W. Aldosterone, mineralocorticoid receptors and vascular inflammation. Mol Cell Endocrinol 217 (2004) 263-269
144. Furst R., Schroeder T., Eilken H.M., et al. MAPK phosphatase-1 represents a novel anti-inflammatory target of glucocorticoids in the human endothelium. FASEB J 21 (2007) 74-80
145. Goulding N.J. The molecular complexity of glucocorticoid actions in inflammation - a four-ring circus. Curr Opin Pharmacol 4 (2004) 629-636
146. Yang Y.H., Toh M.L., Clyne C.D., et al. Annexin 1 negatively regulates IL-6 expression via effects on p38 MAPK and MAPK phosphatase-1. J Immunol 177 (2006) 8148-8153
147. Miner J.N., Diamond M.I., and Yamamoto K.R. Joints in the regulatory lattice: composite regulation by steroid receptor-AP1 complexes. Cell Growth Differ 2 (1991) 525-530
148. Beato M., Herrlich P., and Schütz G. Steroid hormone receptors: many actors in search of a plot. Cell 83 (1995) 851-857
149. Novac N., Baus D., Dostert A., and Heinzel T. Competition between glucocorticoid receptor and NFkappaB for control of the human FasL promoter. FASEB J 20 (2006) 1074-1081
150. Göttlicher M., Heck S., and Herrlich P. Transcriptional cross-talk, the second mode of steroid receptor action. J Mol Med 76 (1998) 480-489
151. Refojo D., Liberman A.C., Holsboer F., and Arzt E. Transcription factor-mediated molecular mechanisms involved in the functional cross-talk between cytokines and glucocorticoids. Immunol Cell Biol 79 (2001) 385-394
152. Herrlich P. Cross-talk between glucocorticoid receptor and AP-1. Oncogene 20 (2001) 2465-2475
153. Jenkins B.D., Pullen C.B., and Darimont B.D. Novel glucocorticoid receptor coactivator effector mechanisms. Trends Endocrinol Metab 12 (2001) 122-126
154. Kino T., Slobodskaya O., Pavlakis G.N., and Chrousos G.P. Nuclear receptor coactivator p160 proteins enhance the HIV-1 long terminal repeat promoter by bridging promoter-bound factors and the Tat-P-TEFb complex. J Biol Chem 277 (2002) 2396-2405
155. Rudiger J.J., Roth M., Bihl M.P., et al. Interaction of C/EBPα and the glucocorticoid receptor in vivo and in nontransformed human cells. FASEB J 16 (2002) 177-184
156. Jensen L.E., and Whitehead A.S. Regulation of serum amyloid A protein expression during the acute-phase response. Biochem J 334 (1998) 489-503
157. Sheppard K.-A., Phelps K.M., Williams A.J., et al. Nuclear integration of glucocorticoid receptor and nuclear factor-κB signaling by CREB-binding protein and steroid receptor coactivator-1. J Biol Chem 273 (1998) 29291-29294
158. De Bosscher K., Vanden Berghe W., Vermeulen L., Plaisance S., Boone E., and Haegeman G. Glucocorticoids repress NF-κB-driven genes by disturbing the interaction of p65 with the basal transcription machinery, irrespective of coactivator levels in the cell. Proc Natl Acad Sci USA 97 (2000) 3919-3924
159. Deroo B.J., and Archer T.K. Glucocorticoid receptor activation of the IκBα promoter within chromatin. Mol Biol cell 12 (2001) 3365-3374
160. McKay L.I., and Cidlowski J.A. CBP (CREB binding protein) integrates NF-kappaB (nuclear factor-kappaB) and glucocorticoid receptor physical interactions and antagonism. Mol Endocrinol 14 (2000) 1222-1234
161. Doucas V., Shi Y., Miyamoto S., West A., Verma I., and Evans R.M. Cytoplasmic catalytic subunit of protein kinase A mediates cross- repression by NF-κB and the glucocorticoid receptor. Proc Natl Acad Sci USA 97 (2000) 11893-11898
162. Cipitelli M., Sica A., Viggiano V., et al. Negative transcriptional regulation of the interferon-γ promoter by glucocortcoids and dominant negative mutants of c-Jun. J Biol Chem 270 (1995) 12548-12556
163. Reichardt H.M., Kaestner K.H., Tuckermann J., et al. DNA binding of the glucocorticoid receptor is not essential for survival. Cell 93 (1998) 531-541
164. Tuckermann J.P., Reichardt H.M., Arribas R., Richter K.H., Schutz G., and Angel P. The DNA binding-independent function of the glucocorticoid receptor mediates repression of AP-1-dependent genes in skin. J Cell Biol 147 (1999) 1365-1370
165. Reichardt H.M., Tuckermann J.P., Gottlicher M., et al. Repression of inflammatory responses in the absence of DNA binding by the glucocorticoid receptor. EMBO J 20 (2001) 7168-7173